Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             178 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Aacr 1993 1993
29 Supplement 4 p. 648-
1 p.
artikel
2 A comparison of the inhibitory effects on DNA-synthesis of cisplatin, doxorubicin and 4-hydroperoxy-cyclophosphamide in cultured human lip carcinoma cells and normal oral keratinocytes Langkjer, S.T.
1993
29 Supplement 4 p. S140-
1 p.
artikel
3 Activity and unexpected lung toxicity of the sequential administration of two alkylating agents—Dacarbazine and fotemustine—in patients with melanoma Gerard, Béatrice
1993
29 Supplement 4 p. 711-719
9 p.
artikel
4 Activity of cisplatin in adenocarcinoma of the pancreas Wils, J.A.
1993
29 Supplement 4 p. 203-204
2 p.
artikel
5 Adjuvant chemotherapy with a nitrosourea-based protocol in advanced malignant melanoma Karakousis, C.
1993
29 Supplement 4 p. 1831-1835
5 p.
artikel
6 Adjuvant combination chemotherapy (AMF) following radical resection of carcinoma of the pancreas and papilla of vater—results of a controlled, prospective, randomised multicentre study Bakkevold, K.E.
1993
29 Supplement 4 p. 698-703
6 p.
artikel
7 AIDS associated non nosgkin lymphomas (NHL): Retrospective analysis Schmilovich, A.
1993
29 Supplement 4 p. S45-
1 p.
artikel
8 Anticancer agents of similar chemical structure show different mutagenic activities Voutsinas, G.
1993
29 Supplement 4 p. S88-
1 p.
artikel
9 Anticlastogenic effects of 13-cis-retinoic acid in vitro Trizna, Zoltán
1993
29 Supplement 4 p. 137-140
4 p.
artikel
10 A phase I/II study of a stepwise dose-escalated regimen of cisplatin, etoposide and ifosfamide plus granulocyte-macrophage colony-stimulating factor (GM-CSF) in patients with advanced germ cell tumours Bokemeyer, C.
1993
29 Supplement 4 p. 2225-2231
7 p.
artikel
11 A phase II study of cisplatin plus methotrexate with folinic acid rescue in metastatic or locally recurrent transitional cell carcinoma of the urothelium Flemming Geertsen, Poul
1993
29 Supplement 4 p. 347-350
4 p.
artikel
12 A pilot study of intensive cyclophosphamide, epirubicin and fluorouracil in patients with axillary node positive or locally advanced breast cancer Levine, Mark N.
1993
29 Supplement 4 p. 37-43
7 p.
artikel
13 A pilot study of intraarterial chemotherapy (IAC) in metastatic colorectal carcinoma (CC) Cyjon, A.
1993
29 Supplement 4 p. S93-
1 p.
artikel
14 A pre-peritoneal continent ileal reservoir with hydraulic valve in the treatment of bladder carcinoma Ronzoni, G.
1993
29 Supplement 4 p. S230-
1 p.
artikel
15 A randomized double-blind placebo-controlled study of org 2766, an acth (4–9) analogue, for the prevention of neuropathy induced by cisplatin (P) with or without vincaalcaloids (VA) combination chemotherapy (CT) Chraibi, Y.
1993
29 Supplement 4 p. S206-
1 p.
artikel
16 Assessing of quality of life (QOL) in a Turkish oncology setting Ozyilkan, O
1993
29 Supplement 4 p. S214-
1 p.
artikel
17 Biological, physical, mental and social dimensions of breast cancer: Information based on routine case notes Holli, Kaija
1993
29 Supplement 4 p. 2152-2155
4 p.
artikel
18 Black (air-cured) and blond (flue-cured) tobacco cancer risk IV: Molecular dosimetry studies implicate aromatic amines as bladder carcinogens Bartsch, H.
1993
29 Supplement 4 p. 1199-1207
9 p.
artikel
19 Breast cancer chemoprevention Costa, Alberto
1993
29 Supplement 4 p. 589-592
4 p.
artikel
20 Breast cancer screening in the context of disease natural history Duffy, S.W.
1993
29 Supplement 4 p. S25-
1 p.
artikel
21 CA 15.3 determination in patients with breast cancer: Clinical utility for the detection of distant metastases Bombardieri, Emilio
1993
29 Supplement 4 p. 144-146
3 p.
artikel
22 Can spect-SCC-immunoscintigraphy improve the radiation therapy planning of squamous cell carcinoma of head and neck? Adamietz, I.A.
1993
29 Supplement 4 p. S138-
1 p.
artikel
23 Carboplatin as second line treatment for recurrent or progressive brain metastases from small cell lung cancer Groen, H.J.M.
1993
29 Supplement 4 p. 1696-1699
4 p.
artikel
24 Carboplatin in advanced hormone refractory prostatic cancer patients Canobbio, Luciano
1993
29 Supplement 4 p. 2094-2096
3 p.
artikel
25 Carboplatin plus epirubicin plus VP-16, concurrent radiotherapy and “adjuvant surgery” for limited small cell lung cancer (SCLC) Gridelli, C.
1993
29 Supplement 4 p. S156-
1 p.
artikel
26 Carcinoma of the cervical stump: A review of 213 cases Barillot, I.
1993
29 Supplement 4 p. 1231-1236
6 p.
artikel
27 CA 125 serum levels in the early post-operative period do not reflect tumour reduction obtained by cytoreductive surgery Yedema, C.A.
1993
29 Supplement 4 p. 966-971
6 p.
artikel
28 CEA-immunoscintigraphy with 99m-technetium correlates with tumour cell differentiation in colorectal cancer Wittig, Bianca M
1993
29 Supplement 4 p. 1327-1329
3 p.
artikel
29 Cell proliferation of breast cancer evaluated by anti-BrdU and anti-Ki-67 antibodies: Its prognostic value on short-term recurrences Gaglia, Piero
1993
29 Supplement 4 p. 1509-1513
5 p.
artikel
30 Cervical cancer incidence and mortality trends in finland and estonia: a screened vs. an unscreened population Aareleid, T.
1993
29 Supplement 4 p. 745-749
5 p.
artikel
31 Chemotherapy induced amenorrhoea in a randomised trial of adjuvant chemotherapy duration in breast cancer Reyno, Leonard M.
1993
29 Supplement 4 p. 21-23
3 p.
artikel
32 Circadian rhythm-modulated chemotherapy with high-dose 5-fluorouracil: a pilot study in patients with pancreatic adenocarcinoma Bertheault-Cvitkovic, F.
1993
29 Supplement 4 p. 1851-1854
4 p.
artikel
33 Clinical pharmacodynamics of 5FU. Significant relationship between response to treatment and systemic dose intensity Milano, G.
1993
29 Supplement 4 p. S109-
1 p.
artikel
34 Clinical results after doxorubicin extravasation treated with excision guided by fluorescence microscopy Andersson, Anders P.
1993
29 Supplement 4 p. 1712-1714
3 p.
artikel
35 Clinical studies with granisetron, a new 5-HT3 receptor antagonist for the treatment of cancer chemotherapy-induced emesis Joss, Rudolf A.
1993
29 Supplement 4 p. S22-S29
8 p.
artikel
36 Colon cancer in seven siblings Ghadirian, Parviz
1993
29 Supplement 4 p. 1553-1556
4 p.
artikel
37 Combined modality therapy for stage IIIA non-small cell carcinoma of the lung Weitberg, Alan B.
1993
29 Supplement 4 p. 511-515
5 p.
artikel
38 Comparative pharmacological, toxicological and antitumoral evaluation of free and liposome-encapsulated cisplatin in rodents Gondal, Javed A
1993
29 Supplement 4 p. 1536-1542
7 p.
artikel
39 Compensatory renal response after unilateral partial and whole volume high-dose irradiation of the human kidney Dewit, L.
1993
29 Supplement 4 p. 2239-2243
5 p.
artikel
40 Control of nausea and vomiting with ondansetron in patients treated with intensive non-cisplatin chemotherapy for acute myeloid leukaemia Braken, J.B.
1993
29 Supplement 4 p. 515-518
4 p.
artikel
41 Curability of advanced Burkitt's lymphoma in children by intensive short-term chemotherapy Gasparini, M.
1993
29 Supplement 4 p. 692-698
7 p.
artikel
42 Cytokine gene expression in primary brain tumours, metastases and meningiomas suggests specific transcription patterns Merlo, Adrian
1993
29 Supplement 4 p. 2118-2125
8 p.
artikel
43 Cytokine gene-transduced tumor cells in cancer therapy: Tumor inhibition by non-specific and specific immune mechanisms Parmiani, G.
1993
29 Supplement 4 p. S15-
1 p.
artikel
44 Cytotoxic effects of anticancer agents on subconfluent and multilayered postconfluent cultures Pizao, Paulo E.
1993
29 Supplement 4 p. 1566-1573
8 p.
artikel
45 21-day schedule oral etoposide in children— a feasibility study Davidson, A.
1993
29 Supplement 4 p. 2223-2225
3 p.
artikel
46 3′-Deamino-3′-(2-methoxy-4-morpholinyl)-doxorubicin (FCE 23762): A new anthracycline derivative with enhanced cytotoxicity and reduced cardiotoxicity Danesi, Romano
1993
29 Supplement 4 p. 1560-1565
6 p.
artikel
47 Delayed emesis following high-dose cisplatin: A double-blind randomised comparative trial of ondansetron (GR 38032F) versus placebo Gandara, D.R.
1993
29 Supplement 4 p. S35-S38
4 p.
artikel
48 De novo cisplatinum resistance does not influence cellular radiosensitivity Britten, Richard A.
1993
29 Supplement 4 p. 1315-1320
6 p.
artikel
49 Differential expression of the intercellular adhesion molecule-1 (ICAM-1) in lung cancer cell lines of various histological types Schardt, Cordula
1993
29 Supplement 4 p. 2250-2255
6 p.
artikel
50 Disease-related differences in antibody patterns against EBV-encoded nuclear antigens EBNA 1, EBNA 2 and EBNA 6 Lennette, Evelyne T.
1993
29 Supplement 4 p. 1584-1589
6 p.
artikel
51 DNA pattern and dietary habits in patients with breast cancer Fürst, Carl Johan
1993
29 Supplement 4 p. 1285-1288
4 p.
artikel
52 Ductal Carcinoma in situ Silverstein, Melvin J.
1993
29 Supplement 4 p. 930-931
2 p.
artikel
53 EAP in advanced gastric cancer Ridolfi, Ruggero
1993
29 Supplement 4 p. 1219-1220
2 p.
artikel
54 Early stage Hodgkin's disease: Ten-year results of a non-randomised study with radiotherapy alone or combined with MOPP Bonfante, Valeria
1993
29 Supplement 4 p. 24-29
6 p.
artikel
55 Effects of different culture protocols on the expression of discrete T-cell receptor variable regions in human tumour infiltrating lymphocytes Filgueira, Luis
1993
29 Supplement 4 p. 1754-1760
7 p.
artikel
56 Endocrine and clinical evaluation of 4-hydroxy-androstenedione in postmenopausal patients with advanced breast cancer (BC) Scanni, A.
1993
29 Supplement 4 p. S82-
1 p.
artikel
57 EO9: A novel bioreductive alkylating indoloquinone with preferential solid tumour activity and lack of bone marrow toxicity in preclinical models Hendriks, H.R.
1993
29 Supplement 4 p. 897-906
10 p.
artikel
58 Epidemiological study of head & neck squamous cell carcinomas (HNSCC) Lefebvre, J.L.
1993
29 Supplement 4 p. S125-
1 p.
artikel
59 Epirubicin, methotrexate and bleomycin in the management of recurrent squamous cell head and neck cancer. A GSTTC randomised phase II study Paccagnella, Adriano
1993
29 Supplement 4 p. 704-708
5 p.
artikel
60 Evaluation of the effect of oral clodronate on skeletal metastases with type 1 collagen metabolites. A controlled trial of the finnish prostate cancer group Kylmälä, T.
1993
29 Supplement 4 p. 821-825
5 p.
artikel
61 Flavone acetic acid and 5,6-dimethylxanthenone-4-acetic acid: Relationship between plasma nitrate elevation and the induction of tumour necrosis Veszelovszky, Edina
1993
29 Supplement 4 p. 404-408
5 p.
artikel
62 Flow cytometry DNA ploidy analysis in children with rhabdomyosarcoma and soft tissue sarcoma Goshen, Y.
1993
29 Supplement 4 p. S186-
1 p.
artikel
63 Folinic acid, 5-fluorouracil bolus and infusion and mitoxantrone with or without cyclophosphamide in metastatic breast cancer Louvet, Christophe
1993
29 Supplement 4 p. 1835-1838
4 p.
artikel
64 Follow-up of breast cancer patients stage I–II: A baseline strategy Hannisdal, E.
1993
29 Supplement 4 p. 992-997
6 p.
artikel
65 Granulocyte colony-stimulating factor (G-CSF) with or without a quinolone in the prevention of infection in cancer patients Maiche, A.G
1993
29 Supplement 4 p. 1403-1405
3 p.
artikel
66 Granulocyte colony-stimulating factor treatment of leucopenia during fractionated radiotherapy Schmidberger, Heinz
1993
29 Supplement 4 p. 1927-1931
5 p.
artikel
67 Growth hormone deficit induced by chemotherapy (CT) in children with cancer Homan, J
1993
29 Supplement 4 p. S198-
1 p.
artikel
68 Hand VS stapled anastomosis in anterior resection Kingston, RD
1993
29 Supplement 4 p. S95-
1 p.
artikel
69 High-dose chemotherapy with autologous bone marrow rescue in advanced stage IV neuroblastoma Philip, T.
1993
29 Supplement 4 p. 487-491
5 p.
artikel
70 High-dose chemotherapy with etoposide, cyclophosphamide and escalating dose of carboplatin followed by autologous bone marrow transplantation in cancer patients. A pilot study Ibrahim, Amad
1993
29 Supplement 4 p. 1398-1403
6 p.
artikel
71 High-dose consolidation chemotherapy in infants with stage 4 neuroblastoma Ladenstein, Ruth
1993
29 Supplement 4 p. 1632-
1 p.
artikel
72 High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study Louvet, Christophe
1993
29 Supplement 4 p. 1217-
1 p.
artikel
73 High dose-intensity chemotherapy, with accelerated cyclophosphamide-doxorubicin-etoposide and granulocyte-macrophage colony stimulating factor, in the treatment of small cell lung cancer Ardizzoni, A.
1993
29 Supplement 4 p. 687-692
6 p.
artikel
74 High failure rate of carboplatin-etoposide combination in good risk non-seminomatous germ cell tumours Kattan, Joseph
1993
29 Supplement 4 p. 1504-1509
6 p.
artikel
75 Hodgkin's disease (HD) patients, clinical stage (CS) I and II, with particular clinical features: staging and therapeutic implications Ponticell, P.
1993
29 Supplement 4 p. S170-
1 p.
artikel
76 4-Hydroxyandrostenedione (4-OHA) as first line treatment in postmenopausal patients with advanced breast cancer(ABC) Zilembo, N.
1993
29 Supplement 4 p. S77-
1 p.
artikel
77 Hyperfractionated radiotherapy and tegafur in local relapse of adenocarcinoma of the rectum: A pilot study Romero, J.
1993
29 Supplement 4 p. S94-
1 p.
artikel
78 IL-4 effect on adhesion molecules on the farage human B-cell lymphoma line Shubinsky, G.
1993
29 Supplement 4 p. S53-
1 p.
artikel
79 Immunodiagnosis of breast cancer by cellscan Rubin, M.
1993
29 Supplement 4 p. S60-
1 p.
artikel
80 Immunodiagnosis of Tumours von Kleist, S.
1993
29 Supplement 4 p. 1622-1630
9 p.
artikel
81 Immunologic changes in children with bone and soft tissue sarcomas Kebudi, R
1993
29 Supplement 4 p. S199-
1 p.
artikel
82 Incidence, survival and mortality in cervical cancer in Norway, 1956–1990 Bjørge, Tone
1993
29 Supplement 4 p. 2291-2297
7 p.
artikel
83 Increased frequency of lymphocyte depletion and mixed cellularity subtypes of Hodgkin's disease in HIV-infected patients Serraino, Diego
1993
29 Supplement 4 p. 1948-1950
3 p.
artikel
84 Increased incidence of sarcoma in patients treated for testicular seminoma Jacobsen, Grete Krag
1993
29 Supplement 4 p. 664-668
5 p.
artikel
85 Induction chemotherapy and intensification with autologous bone marrow reinfusion in patients with locally advanced and disseminated breast cancer Mulder, N.H.
1993
29 Supplement 4 p. 668-671
4 p.
artikel
86 Influence of G-CSF on fludarabine and ARA-C metabolism in AML blasts during therapy Plunkett, W
1993
29 Supplement 4 p. S109-
1 p.
artikel
87 Inhibition of human breast cancer cell growth by N-(4-hydroxyphenyl) retinamide and 13-cis-retinoic acid alone and in combination with tamoxifen Lama, G
1993
29 Supplement 4 p. S122-
1 p.
artikel
88 Initial clinical experience with oral ftorafur and oral 6R,S leucovorin in advanced colorectal carcinoma Manzuik, L.V.
1993
29 Supplement 4 p. 1793-1794
2 p.
artikel
89 Interleukin-2 in combination with interferon-α and 5-fluorouracil for metastatic renal cell cancer Atzpodien, Jens
1993
29 Supplement 4 p. S6-S8
3 p.
artikel
90 1. Introduction 1993
29 Supplement 4 p. S1-S4
4 p.
artikel
91 Isolation of pMGT1: a gene that is repressed by oestrogen and increased by antioestrogens and antiprogestins Manning, D.L.
1993
29 Supplement 4 p. 759-762
4 p.
artikel
92 IV Granisetron in children receiving highly emetogenic chemotherapy: A double-blind dose-ranging study Pinkerton, CR
1993
29 Supplement 4 p. S200-
1 p.
artikel
93 Karyotype in multiple myeloma and plasma cell leukaemia Weh, Hans Josef
1993
29 Supplement 4 p. 1269-1273
5 p.
artikel
94 Laser surgery for small perianal neoplasms Bandieramonte, Gaetano
1993
29 Supplement 4 p. 1528-1531
4 p.
artikel
95 Lipid-bound sialic acid, prostaglandin e and histamine in head and neck cancer Klapan, Ivica
1993
29 Supplement 4 p. 839-845
7 p.
artikel
96 Long term results of treatment in patients with extragonadal germ cell tumours Gutierrez Delgado, F.
1993
29 Supplement 4 p. 1002-1005
4 p.
artikel
97 Low-dose dopamine induces early recovery of recombinant interleukin-2—Impaired renal function Palmieri, G.
1993
29 Supplement 4 p. 1119-1122
4 p.
artikel
98 Making a newly assumed R.N. Part of an oncological intensive care team Allemano, M.C.
1993
29 Supplement 4 p. S258-
1 p.
artikel
99 Mammographic patterns in breast cancer chemoprevention with fenretinide (4-HPR) Cassano, E.
1993
29 Supplement 4 p. 2161-2163
3 p.
artikel
100 4. Management of the patient with an abnormal cervical smear 1993
29 Supplement 4 p. S11-S12
2 p.
artikel
101 Marginal surgery and postoperative radiotherapy in soft tissue sarcomas Wiklund, Tom A.
1993
29 Supplement 4 p. 306-309
4 p.
artikel
102 Metabolic response of AH13r rat tumours to cyclophosphamide as monitored by pO2 and pH semi-microelectrodes Jähde, Eckhard
1993
29 Supplement 4 p. 116-122
7 p.
artikel
103 Metast, malig, melanoma (M. M. M.): Prelim, results of a trial with carboplatin (CB), cis-platinum (DDP), dacarbazine (DTIC), interferon-α (IFNα) and tamoxifen (TAM) Isacson, R
1993
29 Supplement 4 p. S181-
1 p.
artikel
104 Mitoxantrone, folinic acid, 5-fluorouracil and prednisone as first-line chemotherapy for advanced breast carcinoma. A phase II study Carmo-Pereira, J.
1993
29 Supplement 4 p. 1814-1816
3 p.
artikel
105 Mitoxantrone, leucovorin and high-dose infusional 5-fluorouracil: an effective and wellttolerated regimen for the treatment of advanced breast cancer Wils, J.A.
1993
29 Supplement 4 p. 2106-2108
3 p.
artikel
106 Molecular cloning of IGFBP-5 from SCLC cell lines and expression of IGFBP-4, IGFBP-5 and IGFBP-6 in lung cancer cell lines and primary tumours Wegmann, Barbara R
1993
29 Supplement 4 p. 1578-1584
7 p.
artikel
107 Multiple endocrine neoplasia syndromes Brandi, ML
1993
29 Supplement 4 p. S14-
1 p.
artikel
108 Mutagens, N-nitroso compounds and their precursors in gastric juice from patients with and without precancerous lesions of the stomach Pignatelli, B.
1993
29 Supplement 4 p. 2031-2039
9 p.
artikel
109 Neoadjuvant chemotherapy with 4 cycles of cisplatin (P) and 5 fluorouracil (F) in advanced head and neck cancer (AHNC) Casal, J
1993
29 Supplement 4 p. S145-
1 p.
artikel
110 Neoadjuvant treatment for locally advanced bladder cancer: A randomized prospective clinical trial 1993
29 Supplement 4 p. S229-
1 p.
artikel
111 Neuroblastoma: A multiple biological disease Tonini, Gian Paolo
1993
29 Supplement 4 p. 802-804
3 p.
artikel
112 Neuroimmunotherapy of advanced solid neoplasms with single evening subcutaneous injection of low-dose interleukin-2 and melatonin: Preliminary results Lissoni, P
1993
29 Supplement 4 p. 185-189
5 p.
artikel
113 Oncogenes and tumour suppressor genes in transgenic mouse models of neoplasia Fowlis, D.J.
1993
29 Supplement 4 p. 638-645
8 p.
artikel
114 Palliative surgical therapy (PST) in esophageal cancer (EC) Jaśkiewicz, J.
1993
29 Supplement 4 p. S29-
1 p.
artikel
115 Patient perception of the side effects of chemotherapy; the influence of the introduction of 5TH3 antagonists de Boer, M.
1993
29 Supplement 4 p. S264-
1 p.
artikel
116 Phase I and pharmacokinetic study of brequinar (DUP 785; NSC 368390) in cancer patients de Forni, M.
1993
29 Supplement 4 p. 983-988
6 p.
artikel
117 Phase I II study of low-dose intravenous OKT3 and subcutaneous interleukin-2 in metastatic cancer Buter, Jan
1993
29 Supplement 4 p. 2108-2113
6 p.
artikel
118 Phase II study of a short course of weekly cisplatin (C) in locally advanced squamous cell carcinoma (SCC) of the head and neck Planting, A.
1993
29 Supplement 4 p. S141-
1 p.
artikel
119 Phase II study of cisplatin, 5-fluorouracil and folinic acid in patients with carcinoma of unknown primary origin Lenzi, Renato
1993
29 Supplement 4 p. 1634-
1 p.
artikel
120 Phase II study of daily oral miltefosine (hexadecylphosphocholine) in advanced colorectal cancer Planting, A.S.T.
1993
29 Supplement 4 p. 518-519
2 p.
artikel
121 Phase II study of pirarubicin (THP) in patients with cervical, endometrial and ovarian cancer: Study of the clinical screening group of the European Organization for Research and Treatment of Cancer (EORTC) Chauvergne, J.
1993
29 Supplement 4 p. 350-354
5 p.
artikel
122 Phase II study of vinorelbine (Navelbine) in previously treated small cell lung cancer patients Jassem, J.
1993
29 Supplement 4 p. 1720-1722
3 p.
artikel
123 Phase II study of weekly 4′-epidoxorubicin in patients with metastatic squamous cell cancer of the cervix: An EORTC Gynaecological Cancer Cooperative Group Study van der Burg, M.E.L.
1993
29 Supplement 4 p. 147-148
2 p.
artikel
124 Phase II study with liposomal muramyl tripeptide phophatidylethanolamine (MTP/PE) in soft tissue sarcomas (STS) Verweij, J.
1993
29 Supplement 4 p. S184-
1 p.
artikel
125 Phase I study of epirubicin plus vinorelbine with or without G-CSF in advanced non-small cell lung cancer Gridelli, Cesare
1993
29 Supplement 4 p. 1729-1731
3 p.
artikel
126 Phase I study of WR-2721 and carboplatin Budd, G.T.
1993
29 Supplement 4 p. 1122-1127
6 p.
artikel
127 Phase I study on 4-weekly 6 hour infusion of BMY-25067 in patients (PTS) with solid tumors Verweij, J.
1993
29 Supplement 4 p. S119-
1 p.
artikel
128 Post — Operative HDR brachytherapy in the treatment of poor prognosis soft tissue sarcoma Donath, D.
1993
29 Supplement 4 p. S185-
1 p.
artikel
129 Predicting septic complications of chemotherapy: An analysis of 382 patients treated for small cell lung cancer without dose reduction after major sepsis Radford, J.A.
1993
29 Supplement 4 p. 81-86
6 p.
artikel
130 Prednimustine (sterecyt) versus cyclophosphamide both in combination with methotrexate and 5-fluorouracil in the treatment of advanced breast cancer Yosef, H.
1993
29 Supplement 4 p. 1100-1105
6 p.
artikel
131 Prednisolone, cytosine arabinoside, lomustine (CCNU), etoposide and thioguanine (PACET) combination chemotherapy for relapsed or refractory non-Hodgkin lymphoma Sweetenham, John W.
1993
29 Supplement 4 p. 190-192
3 p.
artikel
132 Prevention of emesis by ics 205-930 in children receiving cytotoxic chemotherapy Hachimi-Idrissi, S.
1993
29 Supplement 4 p. 854-856
3 p.
artikel
133 Primary medical (neo-adjuvant) chemotherapy for operable breast cancer Smith, Ian E.
1993
29 Supplement 4 p. 1796-1799
4 p.
artikel
134 Prognostic significance of the pathological subtypes of NS type Hodgkin's disease Kawecki, A.
1993
29 Supplement 4 p. S171-
1 p.
artikel
135 Prognostic value of urokinase-type plasminogen activator (UPA) and its inhibitor PAI-1 in breast cancer Schmitt, M.
1993
29 Supplement 4 p. S31-
1 p.
artikel
136 Prospective randomised trial comparing fluorouracil versus doxifluridine for the treatment of advanced colorectal cancer Bajetta, Emilio
1993
29 Supplement 4 p. 1658-1663
6 p.
artikel
137 Psychosocial adjustment among husbands of women treated for breast cancer; mastectomy vs. breast-conserving surgery Omne-Pontén, M.
1993
29 Supplement 4 p. 1393-1397
5 p.
artikel
138 Psychosocial adjustment six years after primary treatment — Results from a phospective study Omne-Pontén, M
1993
29 Supplement 4 p. S213-
1 p.
artikel
139 Quality assurance in experimental and routine chemotherapy: the role of the clinical research nurse Leieune, M.
1993
29 Supplement 4 p. S260-
1 p.
artikel
140 Quality assurance (QA) - a tool in improving information to patients de Flon, S.
1993
29 Supplement 4 p. S257-
1 p.
artikel
141 Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy Trillet-Lenoir, V.
1993
29 Supplement 4 p. 319-324
6 p.
artikel
142 Recombinant human granulocyte colony-stimulating factor in patients receiving intensive chemotherapy for non-small cell lung cancer Mori, Kiyoshi
1993
29 Supplement 4 p. 677-680
4 p.
artikel
143 Recombinant human interleukin-4 (rhu IL-4) administered by the intravenous and subcutaneous routes in patients with advanced cancer—A phase I toxicity study and pharmacokinetic analysis Prendiville, J.
1993
29 Supplement 4 p. 1700-1707
8 p.
artikel
144 Regulation of insulin-like growth factor binding proteins in ovarian cancer cells by oestrogen Krywicki, Robert F.
1993
29 Supplement 4 p. 2015-2019
5 p.
artikel
145 Response to increasing doses of octreotide in a patient with carcinoid syndrome Ajani, Jaffer A.
1993
29 Supplement 4 p. 2332-2333
2 p.
artikel
146 Results of adjuvant and neo-adjuvant chemotherapy in incipient stages of breast cancer Gabriela, Aldea
1993
29 Supplement 4 p. S74-
1 p.
artikel
147 Results of a double perfusion schedule with melphalan in patients with melanoma of the lower limb Kroon, Bin B.R.
1993
29 Supplement 4 p. 325-328
4 p.
artikel
148 Results of a randomised trial in pelvic malignancy, quality assurance and reduction of morbidity Tait, D
1993
29 Supplement 4 p. S28-
1 p.
artikel
149 Reversal of multidrug resistance by a new lipophilic cationic molecule, S9788. Comparison with 11 other MDR-modulating agents in a model of doxorubicin-resistant rat glioblastoma cells Huet, Sylvie
1993
29 Supplement 4 p. 1377-1383
7 p.
artikel
150 Second malignant tumors (ST) after treatment for Hodgkin's disease (HD) Biti, G.P.
1993
29 Supplement 4 p. S169-
1 p.
artikel
151 Selective reversal of vinblastine resistance in multidrug-resistant cell lines by tamoxifen, toremifene and their metabolites Kirk, J.
1993
29 Supplement 4 p. 1152-1157
6 p.
artikel
152 Serum immunoreactive and bioactive lactogenic hormones in advanced breast cancer patients treated with bromocriptine and octreotide Anderson, Elizabeth
1993
29 Supplement 4 p. 209-217
9 p.
artikel
153 Should further studies of chemotherapy be carried out in pancreatic cancer? Taylor, I.
1993
29 Supplement 4 p. 1076-1078
3 p.
artikel
154 Side-effects of screening Garstin, Ian W.H.
1993
29 Supplement 4 p. 2150-2152
3 p.
artikel
155 Surgical treatment of bone metastases Windhager, R.
1993
29 Supplement 4 p. S44-
1 p.
artikel
156 Surveillance following orchidectomy for stage I seminoma of the testis von der Maase, Hans
1993
29 Supplement 4 p. 1931-1934
4 p.
artikel
157 Systemic treatment in disseminated endometrial cancer Neijt, J.P.
1993
29 Supplement 4 p. 628-632
5 p.
artikel
158 Taboos and pitfalls in pediatric surgical oncology Plaschkes, J.
1993
29 Supplement 4 p. S12-
1 p.
artikel
159 Temozolomide: A new oral cytotoxic chemotherapeutic agent with promising activity against primary brain tumours O'Reilly, S.M.
1993
29 Supplement 4 p. 940-942
3 p.
artikel
160 Testicular cancer after vasectomy: Origin from carcinoma in situ of the testis Jørgensen, N.
1993
29 Supplement 4 p. 1062-1064
3 p.
artikel
161 The outcome of surgery for colorectal cancer in the elderly Kingston, RD
1993
29 Supplement 4 p. S89-
1 p.
artikel
162 The prognostic value of plasminogen-activator inhibitor-1 (PAI-1) and the metastasis-associated proteases urokinase (uPA) and cathepsin-D in primary breast cancer: A multivariate analysis in 657 patients Klijn, JGM
1993
29 Supplement 4 p. S59-
1 p.
artikel
163 Therapy of acute promyelocytic leukemia with all-trans retinoic acid Gillis, S.
1993
29 Supplement 4 p. S42-
1 p.
artikel
164 The real costs of emesis—An economic analysis of ondansetron vs. Metoclopramide in controlling emesis in patients receiving chemotherapy for cancer Cunningham, D.
1993
29 Supplement 4 p. 303-306
4 p.
artikel
165 The use of the polymerase Chain reaction to detect minimal residual disease in childhood acute lymphoblastic leukaemia Oakhill, Anthony
1993
29 Supplement 4 p. 1192-1198
7 p.
artikel
166 This article contains errors and has been withdrawn. A corrected version will be published in a later issue of volume 29 of the European journal of cancer 1993
29 Supplement 4 p. 592-595
4 p.
artikel
167 Tissue polypeptide antigen in breast cancer cytosol: a new effective prognostic indicator Gion, Massimo
1993
29 Supplement 4 p. 66-69
4 p.
artikel
168 Tissue polypeptide-specific antigen: A discriminative parameter between prostate cancer and benign prostatic hypertrophy Marrink, J.
1993
29 Supplement 4 p. 570-571
2 p.
artikel
169 TNM staging of small cell lung cancer Mejholm, B
1993
29 Supplement 4 p. S155-
1 p.
artikel
170 Treatment of melphalan-resistant multiple myeloma with vincristine, BCNU, doxorubicin, and high-dose dexamethasone (VBAD) Bladé, Joan
1993
29 Supplement 4 p. 57-60
4 p.
artikel
171 Treatment of refractory or recurrent small cell lung cancer (SCLC) with cyclophosphamide, cisplatin and vincristine (a non-cross-resistant regimen) Cardenal, F.
1993
29 Supplement 4 p. S157-
1 p.
artikel
172 Treatment results, survival and prognostic factors in 109 inflammatory breast cancers: Univariate and multivariate analysis Attia-Sobol, Jocelyne
1993
29 Supplement 4 p. 1081-1088
8 p.
artikel
173 Trends in cancer mortality in the Americas, 1955–1989 La Vecchia, Carlo
1993
29 Supplement 4 p. 431-470
40 p.
artikel
174 Trends in mortality from malignant cutaneous melanoma in The Netherlands, 1950–1988 Nelemans, P.J.
1993
29 Supplement 4 p. 107-111
5 p.
artikel
175 Tumour necrosis factor-α plasma levels after flavone acetic acid administration in man and mouse Chabot, G.G.
1993
29 Supplement 4 p. 729-733
5 p.
artikel
176 Type I IGF receptor and acquired tamoxifen resistance in oestrogen-responsive human breast cancer cells Wiseman, Lynda R.
1993
29 Supplement 4 p. 2256-2264
9 p.
artikel
177 Vascular density and the response of breast carcinomas to mastectomy and adjuvant chemotherapy Protopapa, Efi
1993
29 Supplement 4 p. 1391-1393
3 p.
artikel
178 Zeniplatin in patients with advanced ovarian cancer, a phase II study with a third generation platinum complex Willemse, P.H.B.
1993
29 Supplement 4 p. 359-362
4 p.
artikel
                             178 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland